The Pfizer booster shot was 95.6 percent effective against Covid-19

BioNTech stated in a tweet, “During a time when Delta was the most common strain, our #mRNA vaccine provided 95.6 percent relative vaccine efficacy against #Covid19 after a booster shot. This is the first time efficacy data from a randomised, controlled vaccine booster trial has been published.”

According to the companies, a booster shot of the BioNTech/Pfizer vaccine is 95.6 percent effective against Covid-19 when compared to those who received two shots and a placebo.

They claimed that a trial of 10,000 people aged 16 and up showed 95.6 percent effectiveness against the diseases during a time when the Delta strain was prevalent.

The booster shot was also found to have a favourable safety profile, according to the study.

Pfizer claimed that the efficacy of its two-shot vaccine decreases over time, citing a study that found 84 percent effectiveness four months after a second dose, down from 96 percent at the start. Some countries had already made plans to administer booster doses.

BioNTech stated in a tweet, “During a time when Delta was the most common strain, our #mRNA vaccine provided 95.6 percent relative vaccine efficacy against #Covid19 after a booster shot. This is the first time efficacy data from a randomised, controlled vaccine booster trial has been published.”

“These findings provide additional evidence of the benefits of boosters as we strive to keep people well-protected against this disease,” said Pfizer CEO Albert Bourla in a statement.

The median age of the participants was 53 years, with 55.5 percent aged 16 to 55 years and 23.3 percent aged 65 or older.

 

 

Medically Speaking

Recent Posts

One Sleepless Night Can Weaken Your Immunity and Trigger Inflammation

Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…

2 days ago

Thick Heart Syndrome: A Silent Threat to Millions in India

Heart disease remains one of the leading causes of death worldwide, and in India, cardiovascular…

2 days ago

Delhi Sees Surge in H1N1 and Influenza B Cases

Delhi is witnessing a sharp rise in flu cases, particularly Influenza B and H1N1 (commonly…

2 days ago

Woman Dies During MRI Scan Due to Medical Negligence

In early February 2025, a tragic incident occurred in Eluru, Andhra Pradesh, where a 61-year-old…

2 days ago

Holi and Eye Safety: Protect Your Vision During Festivities

Holi, the festival of colors, is one of the most vibrant and joyous celebrations in…

3 days ago

FDA Recalls Popular Skincare Products Over Cancer-Causing Chemical

In a major development, the U.S. Food and Drug Administration (FDA) has issued recalls for…

3 days ago